RxDoctor Payments Data

Cynthia Ozawa

Family · Henderson, NVNPI 1871673525

Payments from drug & device makers

$2,396in general payments, 2019–2025

Across 126 payments — averaging $19.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$418
  • Lilly USA, LLC$231
  • Novartis$229
  • Boehringer Ingelheim$221
  • Astellas Pharma US Inc$217
  • Novo Nordisk$199
  • plus $882 from 23 others

What the payments were for

  • Food & beverage$2,33097%
  • Education$663%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,396 in reported general payments places this provider in the 85th percentile of 1,501 family providers in Nevada.

See all family providers in Nevada

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala13$50,929
OzempicSemaglutide41$42,417
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$37,345
JardianceEmpagliflozin19$24,060
XareltoRivaroxaban16$22,301
MounjaroTirzepatide11$18,541
LinzessLinaclotide17$9,899
Breo ElliptaFluticasone/Vilanterol19$7,109
SymbicortBudesonide/Formoterol Fumarate17$6,770
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,608
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen120$2,736
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$2,711
Atorvastatin Calcium254$1,451
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen30$1,306
Albuterol Sulfate HfaAlbuterol Sulfate52$1,052

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy$25$50,92913 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$85$50,06164 claims
Novo NordiskOzempic$199$42,41741 claims
Boehringer IngelheimJardiance$221$24,06019 claims
Johnson & JohnsonXarelto$42$22,30116 claims
Lilly USA, LLCMounjaro$231$18,54111 claims
AbbVieLinzess$418$9,89917 claims
AstraZenecaSymbicort$72$6,77017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,501 family providers in Nevada.

Other family in Henderson

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →